Prof.Dr. MUSTAFA SERHAN SEVİM

Birim
:
Tıp Fakültesi / Nöroloji Anabilim Dalı
İŞ Adresi
: Mersin Üniversitesi Tip Fakültesi Hastane Kampüsü 33110 Yenişehir/ Mersin
Telefon
:
+90--
Dahili
:
URL
:
VCARD
:
/v-card
OLUŞTURMA
:
2015-10-14 11:30:56
DÜZENLEME
:
2019-05-08 15:43:37
PUAN
:
1676
YABANCI DİL
:


Derece Bölüm Üniversite/Kurum Yıl
LİSANS İSTANBUL ÜNİVERSİTESİ 1991
TIPTA UZMANLIK NÖROLOJİ İSTANBUL BAKIRKÖY RUH VE SİNİR HASTALIKLARI HASTANESİ 1999
DOÇENTLİK NÖROLOJİ ÜNİVERSİTELERARASI KURUL 2004
Görev Ünvanı Görev Kurum/Diğer Yıl
ANABİLİM DALI BAŞKANI TIP FAKÜLTESİ 2014-12-01 - 2017-12-01
Uluslararası - SCI, SCI-Expanded, SSCI ve AHCI kategorisine giren 1000
2017
1. SEVİM, M.; KALEAĞASI, Ş.; TAŞDELEN, B. Sulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis. MULTİPLE SCLEROSİS AND RELATED DİSORDERS, 2017, 16, 40-43. 1000 + 0
10.1016/j.msard.2017.05.010

Uluslararası - Alan endexleri 100
2018
1. SEVİM, M. Absenteeism and Delay to Work Due to Sleep Disorders in the Turkish Adult Population: A Questionnaire-Based National Survey. WORKPLACE HEALTH SAFETY, 2018, , 216507991878539-. 100 + 0
10.1177/2165079918785392

Ulusal - SCI, SCI-Expanded, SSCI ve AHCI kategorisine giren 0
2020
18. DEMİRKIRAN, D.; YÜCEYAR, A.; TERZİ, M.; TAŞDELEN, B.; SEVİM, M.; ŞEN, S.; BOZ, C. 'Is RLS a harbinger and consequence of MS?: Striking results of the 'RELOMS-T' study'. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42, -. 0 + 0
10.1016/j.msard.2020.102055

17. YÜCEYAR, A.; SEVİM, M. Ofatumumab versus Teriflunomide in Multiple Sclerosis. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383, -557. 0 + 0
10.1056/NEJMoa1917246

2017
16. SEVİM, M.; TAŞDELEN, B. Sulbutiamine shows promising results in reducing fatigue in patients with multiple sclerosis. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 16, -43. 0 + 0
10.1016/j.msard.2017.05.010

2015
15. SEVİM, M. Sleep bruxism possibly triggered by multiple sclerosis attacks and treated successfully with botulinum toxin: Report of three cases. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2015, 4, -405. 0 + 0
10.1016/j.msard.2015.06.006

2012
14. SEVİM, M. Impact of Fingolimod Therapy on Magnetic Resonance Imaging Outcomes in Patients With Multiple Sclerosis. ARCHIVES OF NEUROLOGY, 2012, 69, -1269. 0 + 0
10.1001/archneurol.2012.1051

2010
13. SEVİM, M. A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362, -401. 0 + 0
10.1056/NEJMoa0909494

2009
12. SEVİM, M. Sciatic injection injuries in adults: Is dipyrone a foe to nerve?. ACTA NEUROLOGICA BELGICA, 2009, 109, -213. 0 + 0
2006
11. ARINCI İNCEL, N.; ANKARALI, H. Assessment of symptom severity and functional status in patients with carpal tunnel syndrome: Reliability and validity of the Turkish version of the Boston Questionnaire. DISABILITY AND REHABILITATION, 2006, 28, -1286. 0 + 0
10.1080/09638280600621469

2005
10. SEVİM, M. Clinical characteristics of essential tremor in Mersin, Turkey - A population-based door-to-door study. JOURNAL OF NEUROLOGY, 2005, 252, -574. 0 + 0
10.1007/s00415-005-0700-8

2004
9. SEVİM, M. Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease. CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 106, -96. 0 + 0
10.1016/j.clineuro.2003.10.012

8. SEVİM, M. Reduced body mass index in patients with essential tremor - A population-based study in the province of Mersin, Turkey. ARCHIVES OF NEUROLOGY, 2004, 61, -389. 0 + 0
7. SEVİM, M.; ANKARALI, H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75, -230. 0 + 0
6. SEVİM, M.; APAYDIN, H. A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion. MOVEMENT DISORDERS, 2004, 19, -816. 0 + 0
10.1002/mds.20028

2003
5. SEVİM, M.; ANKARALI, H. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. NEUROLOGY, 2003, 61, -1569. 0 + 0
4. AKTEKİN, M.; SEVİM, M. Late onset polyneuropathy due to organophosphate (DDVP) intoxication. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2003, 30, -78. 0 + 0
3. ÜNAL, S.; SEVİM, M. Poland's syndrome with rare deformities: reconstruction with latissimus dorsi muscle through a single short incision. SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY, 2003, 37, -306. 0 + 0
10.1080/02844310310000437

2. ANKARALI, H.; ŞAŞMAZ, C.; BUĞDAYCI, R. Prevalence of essential tremor - Door-to-door neurologic exams in Mersin Province, Turkey. NEUROLOGY, 2003, 61, -1806. 0 + 0
1. SEVİM, M. Seizures associated with quetiapine treatment. ANNALS OF PHARMACOTHERAPY, 2003, 37, -1227. 0 + 0
10.1345/aph.1C516

Ulusal - Bilimsel Kitap Yazma (Tez Hariç) 0
1. AYDIN GÜNGÖR, H.; BİR, L.; KÜRTÜNCÜ, M.; SEVİM, M. Multipl Skleroz Tanı ve Tedavi Kılavuzu 2018, ISBN: 978-605-89294-9-4, galenos, Baskı Sayısı: 1, Baskı Adet Sayısı: , Sayfa, Türkçe, , Türkiye, 2018. 0
Uluslararası - Tam Metin - Poster 100

1. SEVİM, M., Let’s raise the awareness of MS specialistsconcerning the frequency and impact of RLS in MS and consequently the life quality ofpatients with MS: Striking results of the ‘RELOMS-T’ Study.. American Academy ofNeurology,, 2018-03-21, 2018-04-27, , , . 100

Uluslararası - Özet - Poster 135

3. SEVİM, M., RLS is an important and frequent cause of depression and anxiety in patients with MS: striking results of the ’xxRELOMS-T’xx. 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, 2018-10-10, 2018-10-12, BERLİN, Almanya, . 50

2. SEVİM, M., Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis. ECTRIMS, 2017-10-10, 2017-10-13, , , . 50

1. SEZGİN, M.; YEŞİLDAL, E.; SEVİM, M.; ANKARALI, H.; ŞAHİN, G., Sleep quality in patients with knee osteoarthritis. EULAR 2017 Kongresi / Madrid, Spain 14-17 June 2017, 2017-06-14, 2017-06-17, , , . 35

Ulusal - Özet - Sözlü 150

3. SEVİM, M., Multipl Skleroz Artık HBS Sekonder Nedenleri Arasında Yerini Almalı! : Bu Alanda Şimdiye Kadar Yapılmış En Geniş Çaplı Çalışmanın(Multipl Sklerozun Huzursuz Bacakları- Türkiye (RELOMS-T)) Çarpıcı Sonuçları. 53. ULUSAL NÖROLOJİ KONGRESİ, 2017-11-24, 2017-11-30, , Türkiye, . 50

2. SEVİM, M., MULTİPL SKLEROZ ARTIK HBS SEKONDER NEDENLERİ ARASINDA YERİNİ ALMALI!: BU ALANDA ŞİMDİYE KADAR YAPILMIŞ EN GENİŞ ÇAPLI ÇALIŞMANIN [MULTİPL SKLEROZUN HUZURSUZ BACAKLARI-TÜRKİYE (RELOMS-T)] ÇARPICI SONUÇLARI. 53. ULUSAL NÖROLOJİ KONGRE, 2017-11-24, 2018-01-30, , Türkiye, . 50

1. SEVİM, M., Multipl Skleroz artık HBS sekonder nedenleri arasında yerini almalı: Bu alanda şimdiye kadar yapılmış en geniş çaplı çalışmanın (Multipl sklerozun huzursuz bacakları-Türkiye) (RELOMS-T)) çarpıcı sonuçları. 53. Ulusal Nöroloji Kongresi, 2017-11-24, 2017-11-30, , Türkiye, . 50

Ulusal - Özet - Poster 41

2. SEVİM, M.; ÖKSÜZ, N.; KALEAĞASI, Ş.; YILMAZ, İ., Fingolimoda bağlı ilaç kesmeyi gerektiren hipertansiyon olgu sunumu. 53. Ulusal Nöroloji Kongresi, 2017-11-24, 2017-11-30, Antalya, Türkiye, . 23

1. SEZGİN, M.; YEŞİLDAL, E.; SEVİM, M.; ANKARALI, H.; ŞAHİN, G., Sleep Quality in Patients with Knee Osteoarthritis. 26. Ulusal FTR Kongresi, 2017-04-25, 2017-04-29, Antalya, Türkiye, . 17

Ulusal - Yürütücü 100

1. MULTIPLE SKLEROZLU HASTALARDA FIZYOTERAPININ HAYAT KALITESI, UYKU, KOGNISYON VE YORGUNLUK ÜZERINE OLAN ETKISININ KONTROL GRUBU VE SAĞLIKLI BIREYLERLE KIYASLANARAK INCELENMESI, BAP, Proje No: 2019-3-TP3-3674, 9363 TL, Yürütücü, Devam ediyor... 100

Ulusal - Araştırmacı 50

1. Primer Progresif Multipl Skleroz’lu Hastalarda Plazma miRNA Ekspreyon Profillerinin Araştırılması, BAP, Proje No: 2020-1-AP4-3949, 35000 TL, Araştırmacı, Devam ediyor... 50